ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Crown Will Offer $924m To Merge With Re
Generics BulletinExecutive changes in the off-patent medicines industry throughout 2023 reflected a growing interest in the innovator side of the life sciences sector among leading generics and biosimilars companies.
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bayer, Twist Collaboration Gives German
Generics BulletinMerck Sharp and Dohme has been fined €38.9m ($39.0m) by Spanish competition regulator the CNMC for abusing its dominant position by blocking Insud Pharma ’s rival to the Nuvaring vaginal contracepti